Innlanz Ltd (inl) Logo

Innlanz Ltd (INL)

___:___ · Consumer Cyclical
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE

INL ASX Chart

Snapshot

Innlanz Limited (INL) (formerly Mediland Pharm Limited) is a Sydney-based company listed on the Australian Securities Exchange. The Company began its journey over 19 years ago focusing on providing the best of Australian and New Zealand health and well-being products to the discerning customer, both local and international visitor alike, at exceptional value. By 2020, the Company was servicing the needs of thousands of visitors annually from China via its five retail outlets in Sydney, Melbourne, the Gold Coast and New Zealand.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -
vs ASX 200 (1yr) -76.73%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 2,230 of 2,387
Sector Rank 142 of 152

Key Fundamentals

Shares Issued
Sector Consumer Cyclical
Similar Companies MHI / MCL / DW8
EPS -$0.002
DPS $0.00
Book Value Per Share $0.009

Broker Consensus

INL is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Parramatta NSW 2150
Website www.innlanz.com
Registry Computershare
Auditor RSM Australia Partners
Date Listed 22 Feb 2019

Upcoming Calendar (Forecasted)

Date Event
29/08/2024 Report (Prelim)
25/09/2024 Report (Annual)
24/10/2024 Report (Annual)
06/03/2025 Report (Interim)

Former Company Names

  • Mediland Pharm Limited (MPH ), 15/12/2021

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

INL directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
03/02/22 Tracey Cray Buy +16,666 $0.060 $999 As advised by the company
03/02/22 Tracey Cray Buy +150,000 $0.067 $10,000 Conversion of securities
03/02/22 Tracey Cray Exercise 150,000 $0.067 $10,000 Conversion of securities
03/02/22 Theo Renard Buy +16,666 $0.060 $999 As advised by the company
03/02/22 Theo Renard Buy +150,000 $0.067 $10,000 Conversion of securities
03/02/22 Theo Renard Exercise 150,000 $0.067 $10,000 Conversion of securities
03/02/22 Peter French Buy +16,666 $0.060 $999 As advised by the company
03/02/22 Peter French Buy +150,000 $0.067 $10,000 Conversion of securities
03/02/22 Peter French Exercise 150,000 $0.067 $10,000 Conversion of securities
02/02/22 Tracey Cray Issued 150,000 $0.060 $9,000 Issue of securities
02/02/22 Theo Renard Issued 150,000 $0.060 $9,000 Issue of securities
02/02/22 Peter French Issued 150,000 $0.060 $9,000 Issue of securities

Director Interests

The current holdings of INL directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Leo (Xiaolei) Cui 27/09/2023 61,000 N/A N/A N/A
Jhon Shen 27/09/2023 N/A 250,000,000 N/A N/A
Theo Renard 27/09/2023 166,666 N/A N/A N/A
Peter French 27/09/2023 166,666 N/A N/A N/A
Yeshween Mudaliar 01/09/2023 2,500,000 2,500,000 N/A N/A

Shareholder Info

Top 20 Shareholders

Data supplied by Morningstar and accurate on Sep 26, 2023.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
Pacific Merchants Group Limited 250,000,000 79.80%
Mr Qiming Du 13,190,811 4.21%
Mr Yongqiang Lu 10,000,000 3.19%
Ms Xiyao Sun 10,000,000 3.19%
Aussia Pharmaceuticals Pty Ltd <Yan Family A/C> 2,700,000 0.86%
Yun Liu 2,536,236 0.81%
Ms Ming Xu <Xu Family A/C> 2,500,000 0.80%
Wei Liu 1,999,910 0.64%
Mr Zhixiong Li 1,996,000 0.64%
Mr Tissa Wijesuriya 1,007,698 0.32%
Lei Wang 1,000,000 0.32%
Mrs Li Chen 1,000,000 0.32%
Ms Jun Yan 1,000,000 0.32%
Weiqing Ye 1,000,000 0.32%
Ms Xiyao Sun i 950,383 0.30%
Xinjia Cui 855,600 0.27%
Ms Yi Liu 764,000 0.24%
Yuanbo Lian 500,000 0.16%
Mr Eldo Nirakkallungal Pappachan and Ms Riby Kuriachan <N P Family A/C> 400,000 0.13%
Mr Chuang Wang 384,667 0.12%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 13 43 86 134 42 318

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
Pacific Merchants Group Limited 26/09/2023 250,000,000 79.80

Shareholders Buying

12 month transaction history compiled from ASX announcements.

No buy transactions reported by Substantial Shareholders in the past 12 months.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2023 $0.028 30 June
2022 $0.059 30 June
INL Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.